Triasima Portfolio Management Inc. Eli Lilly & CO Transaction History

Triasima Portfolio Management Inc.

$387 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $22,470 - $28,180	-31 Reduced 0.31%	9,914 $8.98 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $1.88 Million - $2.52 Million	-3,182 Reduced 24.24%	9,945 $7.74 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $705,855 - $832,110	-1,344 Reduced 9.29%	13,127 $7.65 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $323,851 - $446,478	-745 Reduced 4.9%	14,471 $7.77 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $173,967 - $232,614	-496 Reduced 3.16%	15,216 $7.14 Million
Q1 2023 Apr 28, 2023	SELL	$310.63 - $364.82 $5.33 Million - $6.25 Million	-17,145 Reduced 52.18%	15,712 $5.4 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $3.15 Million - $3.68 Million	9,809 Added 42.56%	32,857 $12 Million
Q3 2022 Mar 10, 2023	SELL	$296.48 - $337.87 $62,260 - $70,952	-210 Reduced 0.94%	22,062 $7.13 Million
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $62,260 - $70,952	-210 Reduced 0.9%	23,048 $7.52 Million
Q2 2022 Mar 10, 2023	BUY	$278.73 - $327.27 $741,421 - $870,538	2,660 Added 13.56%	22,272 $7.22 Million
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $741,421 - $870,538	2,660 Added 12.91%	23,258 $7.54 Million
Q1 2022 Mar 10, 2023	SELL	$234.69 - $291.66 $3.11 Million - $3.86 Million	-13,245 Reduced 40.31%	19,612 $5.62 Million
Q1 2022 Jul 20, 2022	BUY	$234.69 - $291.66 $366,820 - $455,864	1,563 Added 8.21%	20,598 $5.9 Million
Q4 2021 Mar 10, 2023	BUY	$224.85 - $279.04 $354,138 - $439,488	1,575 Added 9.02%	19,035 $5.26 Million
Q4 2021 Jul 20, 2022	BUY	$224.85 - $279.04 $354,138 - $439,488	1,575 Added 9.02%	19,035 $5.27 Million
Q3 2021 Mar 10, 2023	BUY	$221.6 - $272.71 $1.05 Million - $1.3 Million	4,760 Added 37.48%	17,460 $4.03 Million
Q3 2021 Jul 20, 2022	BUY	$221.6 - $272.71 $1.05 Million - $1.3 Million	4,760 Added 37.48%	17,460 $4.03 Million
Q2 2021 Mar 10, 2023	BUY	$180.55 - $233.54 $798,031 - $1.03 Million	4,420 Added 53.38%	12,700 $2.92 Million
Q2 2021 Jul 20, 2022	BUY	$180.55 - $233.54 $798,031 - $1.03 Million	4,420 Added 53.38%	12,700 $2.91 Million
Q4 2020 Mar 10, 2023	SELL	$130.46 - $172.63 $3.21 Million - $4.24 Million	-24,577 Reduced 74.8%	8,280 $1.4 Million
Q4 2020 Jul 20, 2022	BUY	$130.46 - $172.63 $1.08 Million - $1.43 Million	8,280 New	8,280 $1.4 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.3 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Triasima Portfolio Management Inc. with notifications on news.

Account